135 related articles for article (PubMed ID: 7202482)
1. Cardiovascular actions of mixidine fumarate.
Takeda K; Akera T; Brody TM
Eur J Pharmacol; 1980 Nov; 68(2):129-37. PubMed ID: 7202482
[No Abstract] [Full Text] [Related]
2. Cardiovascular profile of mixidine fumarate, a compound which attenuates myocardial chronotropic responses.
Pruss TP; Hageman WE; Jacoby HI
J Pharmacol Exp Ther; 1980 Mar; 212(3):514-8. PubMed ID: 7359351
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
Kobinger W; Lillie C
Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
5. Mechanical function and metabolism of working rat hearts perfused with the negative chronotropic agent mixidine fumarate.
Rovetto MJ
Proc Soc Exp Biol Med; 1980 May; 164(1):13-7. PubMed ID: 7375471
[No Abstract] [Full Text] [Related]
6. Cardiovascular effects of orciprenaline (Alupent) inhalation and prednisolone.
Prasad K; Szabo L
Adv Myocardiol; 1980; 1():437-52. PubMed ID: 7394342
[No Abstract] [Full Text] [Related]
7. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system].
Nakamura T; Miura Y; Aihara K; Satoh H; Goto K; Tsumagari T
Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):79-92. PubMed ID: 6137441
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cardiovascular responses to the bradycardic drugs, alinidine, AQ-A 39, and mixidine, in the anesthetized dog.
Siegl PK; Wenger HC; Sweet CS
J Cardiovasc Pharmacol; 1984; 6(4):565-74. PubMed ID: 6206308
[TBL] [Abstract][Full Text] [Related]
9. The cardiovascular actions of 1-methylisoguanosine.
Marwood JF
Clin Exp Pharmacol Physiol; 1981; 8(6):575-84. PubMed ID: 7333043
[TBL] [Abstract][Full Text] [Related]
10. Effects of vanadate on heart and circulation.
Borchard U; Greeff K; Hafner D; Noack E; Rojsathaporn K
J Cardiovasc Pharmacol; 1981; 3(3):510-21. PubMed ID: 6168832
[TBL] [Abstract][Full Text] [Related]
11. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
Zechel HJ
Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
[No Abstract] [Full Text] [Related]
12. [A study of cardiovascular and antiarrhythmic effects of alizapride (author's transl)].
Cheymol G; Mouillé P
Sem Hop; 1982 Feb; 58(6):333-8. PubMed ID: 6280298
[No Abstract] [Full Text] [Related]
13. AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart.
Kobinger W; Lillie C
Eur J Pharmacol; 1981 Jun; 72(2-3):153-64. PubMed ID: 7250205
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular depressant effects of the kappa opioid receptor agonists U50488H and spiradoline mesylate.
Hall ED; Wolf DL; McCall RB
Circ Shock; 1988 Dec; 26(4):409-17. PubMed ID: 2850873
[TBL] [Abstract][Full Text] [Related]
15. The influence of chemical restraining agents on cardiovascular function: a review.
Parker JL; Adams HR
Lab Anim Sci; 1978 Oct; 28(5):575-83. PubMed ID: 102871
[TBL] [Abstract][Full Text] [Related]
16. Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action.
Côté P; Polumbo RA; Harrison DC
Cardiovasc Res; 1974 Nov; 8(6):721-30. PubMed ID: 4457225
[No Abstract] [Full Text] [Related]
17. Cardiovascular actions of N-allyl-clonidine (ST 567), a substance with specific bradycardic action.
Kobinger W; Lillie C; Pichler L
Eur J Pharmacol; 1979 Sep; 58(2):141-50. PubMed ID: 499344
[No Abstract] [Full Text] [Related]
18. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
Urbaszek W; Kalkowski H; Günther K; Splith G; Trenckmann H
Z Gesamte Inn Med; 1969 Feb; 24(4):102-8. PubMed ID: 4978753
[No Abstract] [Full Text] [Related]
19. Test of the usefulness of a paradigm to identify potential cardiovascular liabilities of four test articles with varying pharmacological properties in anesthetized guinea pigs.
Kijtawornrat A; Ueyama Y; del Rio C; Sawangkoon S; Buranakarl C; Chaiyabutr N; Hamlin RL
Toxicol Sci; 2014 Feb; 137(2):458-68. PubMed ID: 24189130
[TBL] [Abstract][Full Text] [Related]
20. Investigations into the pharmacological effects of spongiatriol.
Marwood JF
Aust J Exp Biol Med Sci; 1982 Jun; 60(3):253-63. PubMed ID: 7150416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
